232 related articles for article (PubMed ID: 8659452)
1. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms.
Nakase K; Kita K; Shiku H; Tanaka I; Nasu K; Dohy H; Kyo T; Tsutani H; Kamada N
Am J Clin Pathol; 1996 Jun; 105(6):761-8. PubMed ID: 8659452
[TBL] [Abstract][Full Text] [Related]
2. CD4 predicts nonlymphocytic lineage in acute leukemia. Insights from analysis of 125 cases using two-color flow cytometry.
Larson RS; McCurley TL
Am J Clin Pathol; 1995 Aug; 104(2):204-11. PubMed ID: 7543728
[TBL] [Abstract][Full Text] [Related]
3. Expression pattern of hybrid phenotype in adult acute lymphoblastic leukemia.
Nakase K; Kita K; Miwa H; Nishii K; Shiku H; Nasu K; Dohy H; Kyo T; Kamada N; Tsutani H
Cancer Detect Prev; 2001; 25(4):394-405. PubMed ID: 11531016
[TBL] [Abstract][Full Text] [Related]
4. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
[TBL] [Abstract][Full Text] [Related]
5. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
[TBL] [Abstract][Full Text] [Related]
6. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
Leuk Lymphoma; 2001 Jun; 42(1-2):75-82. PubMed ID: 11699224
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
8. Cellular characteristics of acute leukemia cells simultaneously expressing CD13/CD33, CD7 and CD19.
Mizutani M; Miwa H; Takahashi T; Katoh K; Shikami M; Katayama N; Shiku H; Kita K
Int J Hematol; 1997 Dec; 66(4):479-91. PubMed ID: 9479874
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
Seshi B; Kashyap A; Bennett JM
Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546
[TBL] [Abstract][Full Text] [Related]
10. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
Leuk Lymphoma; 2001 Aug; 42(4):675-82. PubMed ID: 11697497
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro expression of myeloid antigens on B-lineage acute lymphoblastic leukemia cells.
Hara J; Kawa-Ha K; Yumura-Yagi K; Kurahashi H; Tawa A; Ishihara S; Inoue M; Murayama N; Okada S
Leukemia; 1991 Jan; 5(1):19-25. PubMed ID: 1705635
[TBL] [Abstract][Full Text] [Related]
12. Acute lymphoblastic leukemia accompanied by chromosomal abnormality of translocation (12;17).
Asahara SI; Saigo K; Hasuike N; Tamura M; Maeda Y; Tomofuji Y; Chinzei T; Tatsumi E
Haematologia (Budap); 2001; 31(3):209-13. PubMed ID: 11855782
[TBL] [Abstract][Full Text] [Related]
13. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia.
Drexler HG; Thiel E; Ludwig WD
Leukemia; 1991 Aug; 5(8):637-45. PubMed ID: 1886419
[TBL] [Abstract][Full Text] [Related]
14. Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.
Vitale A; Guarini A; Ariola C; Meloni G; Perbellini O; Pizzuti M; De Gregoris C; Mettivier V; Pastorini A; Pizzolo G; Vignetti M; Mandelli F; Foà R
Haematologica; 2007 Mar; 92(3):342-8. PubMed ID: 17339183
[TBL] [Abstract][Full Text] [Related]
15. CD4+, CD33-, CD13-, CD14- acute monoblastic leukaemia.
Lombard EH; Mansvelt EP
Acta Haematol; 1992; 87(3):151-2. PubMed ID: 1379402
[TBL] [Abstract][Full Text] [Related]
16. Myeloid surface antigen expression in adult acute lymphoblastic leukemia.
Guyotat D; Campos L; Shi ZH; Charrin C; Treille D; Magaud JP; Fiere D
Leukemia; 1990 Sep; 4(9):664-6. PubMed ID: 1697640
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications.
Lauria F; Raspadori D; Martinelli G; Rondelli D; Ventura MA; Farabegoli P; Tosi P; Testoni N; Visani G; Zaccaria A
Br J Haematol; 1994 Jun; 87(2):286-92. PubMed ID: 7947269
[TBL] [Abstract][Full Text] [Related]
18. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
19. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia.
Abdelhaleem M
Exp Mol Pathol; 2007 Aug; 83(1):138-41. PubMed ID: 17434163
[TBL] [Abstract][Full Text] [Related]
20. [Application of flow cytometry in the differential diagnosis of lymphoma/leukemia with aberrant antigen expression].
Xia CQ; Chen SL; Qi M; Xu XF
Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):532-5. PubMed ID: 15634450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
